GILD Gilead Sciences, Inc.

Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Gilead Sciences, Inc. market cap is $82.25B.

52 week high is the highest price of a stock in the past 52 weeks, or one year. Gilead Sciences, Inc. 52 week high is $87.87 as of May 15, 2024.

52 week low is the lowest price of a stock in the past 52 weeks, or one year. Gilead Sciences, Inc. 52 week low is $64.33 as of May 15, 2024.

Gilead Sciences, Inc. stock price today is $67.42.

Gilead Sciences, Inc. stock price yesterday was $67.65.

The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Gilead Sciences, Inc.’s P/E ratio is 183.89.

The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Gilead Sciences, Inc. P/B ratio is 4.6859.

EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Gilead Sciences, Inc.'s EBITDA is 9.14.

The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Gilead Sciences, Inc. 50-day moving average is $69.80.

Gilead Sciences, Inc. has 18,000 employees.